Showing results (321-330 of 791) with videos related to
Sort By:
Pageof 80
Neurobiology of Aging|September 11, 2019
Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regionsNick A Weaver, Thomas Doeven, Frederik Barkhof, et al.The Clinical Neuropsychologist|June 15, 2026
Concordance between domain-based neuropsychological profiles and clinical phenotypes in young-onset dementiaJohan W A Renssen, Sietske A M Sikkes, Sophie M van der Landen, et al.Annals of Clinical and Translational Neurology|January 9, 2021
Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-oldWiesje Pelkmans, Nienke Legdeur, Mara Ten Kate, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 10, 2016
A novel CCM2 variant in a family with non-progressive cognitive complaints and cerebral microbleedsPetra E Cohn-Hokke, Henne Holstege, Marjan M Weiss, et al.Stroke|September 6, 2005
Small vessel disease and general cognitive function in nondisabled elderly: the LADIS studyWiesje M van der Flier, Elizabeth C W van Straaten, Frederik Barkhof, et al.Neurology|October 21, 2018
Clinical phenotype, atrophy, and small vessel disease in <i>APOE</i>ε2 carriers with Alzheimer diseaseColin Groot, Carole H Sudre, Frederik Barkhof, et al.AJNR. American Journal of Neuroradiology|May 3, 2008
Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensitiesA J Bastos-Leite, J P A Kuijer, S A R B Rombouts, et al.Brain : a Journal of Neurology|August 25, 2020
A clinical-radiological framework of the right temporal variant of frontotemporal dementiaHulya Ulugut Erkoyun, Colin Groot, Ronja Heilbron, et al.Alzheimer'S Research & Therapy|January 9, 2020
Methylphenidate and galantamine in patients with vascular cognitive impairment-the proof-of-principle study STREAM-VCIJolien F Leijenaar, Geert Jan Groeneveld, Erica S Klaassen, et al.Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.Pageof 80